OrbiMed
Highly Engaged Employees
Finance · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
601 Lexington Avenue at 53rd St Fl 54, N...Phone Number
(212) 739-6400Website
www.orbimed.comRevenue
$38.3 MillionIndustry
About OrbiMed
OrbiMed Org Chart
Is OrbiMed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if OrbiMed had a recent Job posting/layoffs
Check out if OrbiMed is spiking on competitors!
Product Launch: Get notified when OrbiMed launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on OrbiMed recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at OrbiMed
OrbiMed, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once OrbiMed has new funding data
Check if OrbiMed has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at OrbiMed
Find 2 more new buyers
Compare Similar Companies to OrbiMed
Compare insights from companies similar to OrbiMed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OrbiMed is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
OrbiMed is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about OrbiMed.
OrbiMed Tech Stack
A closer look at the technologies used by OrbiMed
Most Recent Scoops
OrbiMed News & Media
Vivacta Bio Closed Series A and Series A+ Financing of Over US$50 Million
Backed by Decheng Capital, Loyal Valley Capital, OrbiMed, and Other Renowned Investors SHANGHAI, April 29, 2026 /PRNewswire/ -- Vivacta Biotechnology (Shanghai) Co., Ltd. ("Vivacta" or "Vivacta Bio"), an innovative biotechnology company focused on revolutionizing in vivo CAR-T therapies,...OrbiMed cuts Adicet Bio (ACET) holdings to 8.8% after share sales - Stock Titan
OrbiMed files Amendment No. 9, revealing Adicet Bio ownership reduced to 8.8% of 9.6M shares outstanding after recent open-market sales by several affiliated funds.SpectronRx Secures $85 Million to Expand Medical Isotope Production, CDMO and CMO ...
34-acre campus supports 200,000 square feet of GMP manufacturing, with long-term expansion capacity exceeding one million square feetPinnacle Medicines, a Pioneer of Oral Peptide Therapeutics, Announces Oversubscribed $89 Million Series B Financing to Advance Pipeline into Clinical Trials
Financing co-led by LAV and Foresite Capital with participation from Quan Capital, Hankang Capital, RA Capital Management, Logos Capital and existing investors including OrbiMed Company has raised $134 million to date following incubation by OrbiMed and other healthcare specialist...
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OrbiMed
OrbiMed Advisors LLC operates as a specialized investment firm focused on the healthcare sector, with deep expertise spanning multiple therapeutic and commercial domains. The firm manages capital across biopharmaceuticals, medical devices, digital health platforms, diagnostics, and healthcare services, bringing together investment professionals wit... Read More


